Study: fewer and fewer Germans want to be against Corona vaccinated

The Corona-pandemic keeps the world in breath. More than 12 million people were infected with the novel Coronavirus, 198.546 of them in Germany. The United States reported almost daily new record numbers.

Study: fewer and fewer Germans want to be against Corona vaccinated

The willingness to Corona vaccination is declined according to one study, in Germany. Thus, the share of supporters had declined in the past three months, from 70 to 61 percent, reported the "Süddeutsche Zeitung" on Sunday, citing a survey. The University of Hamburg was asked, in cooperation with universities of other EU countries, thousands of people in several countries as a vaccine against the Coronavirus. So far, there is not such a vaccination.

Particularly low Impfbereitschaft in Germany is reported to be 52 per cent, in Bavaria, in the North of Germany, she was 67 per cent, is significantly higher. An East-West divide was not there.

Jonas Schreyögg, head of the Hamburg Center for Health Economics at the University of Hamburg said, according to the "Süddeutscher Zeitung", there is, however, only a few people refuse the vaccine in General. "Positively speaking, this means that if we are able to provide transparency in the examination and approval of vaccines, as well as with public awareness campaigns to these people more security and to convince you, the Impfbereitschaft significantly werden&quot increases;, he says. A large proportion of those who want to be currently vaccinated, or are unsure, would this be justified with fear of side effects or lack of clarity on the safety of the vaccine.

Schreyögg said that awareness campaigns would not be useful. It appears particularly important to him, to convince women. You are "across all age groups uncertain about the Impfentscheidung".

The latest news on Corona-crisis in Germany, Europe and the world read in the News-Ticker of FOCUS Online.  

All the important messages to the Coronavirus in the FOCUS Online Newsletter. Subscribe now.